课题基金 / 基金详情

项目摘要

项目成果

Carlos L Arteaga的其他基金

相似基金

相关文献

中文摘要
翻译
范德比尔特大学医学中心(VUMC)和NCI指定的范德比尔特-英格拉姆综合医院 癌症中心(VICC)已采取具体行动,以提高机会的数量和质量, 为翻译/临床研究者、实验室医生-科学家提供翻译研究培训 和基础科学家。这些行动对于乳房孢子的成功至关重要, 以及成功地将实验室取得的进展应用于我们的最终目标:减少 乳腺癌的发病率、发病率和死亡率。为了实现这些总体目标, 职业发展计划(CDP)。发展政策委员会的具体目标如下: 招募,支持和发展年轻的医生,科学家和实验室为基础的翻译/临床 研究人员(MD和MD/PhD)进入乳腺癌研究 招募、支持和培养年轻的基础科学家(博士)从事以机制为基础的应用研究, 乳腺癌 招募优秀的基础科学家进入乳腺癌研究领域,并提供临床和翻译服务。 这项研究的专业知识 为研究人员提供转化研究指导、培训和机会, 知识,技能和专业知识,以成功地追求独立,校外资助的学术 职业生涯集中在乳腺癌的转化研究 高度优先征聘妇女和任职人数不足的少数群体调查员, 乳腺癌的研究
英文摘要
Vanderbilt University Medical Center (VUMC) and the NCI-designated Vanderbilt-lngram Comprehensive Cancer Center (VICC) have taken specific actions to improve the quantity and quality of opportunities for training in translational research available to translational/clinical investigators, laboratory-based physician-scientists and basic scientists. These actions are of vital importance for the success of the Breast SPORE as well as for the successful application of progress made in the laboratory to our ultimate goal: a reduction in the incidence, morbidity and mortality resulting from breast cancer. To achieve these overall goals, the SPORE includes a Career Development Program (CDP). Specific aims of the CDP are as follows: To recruit, support and develop young physician-scientists and laboratory-based translational/clinical investigators (MD and MD/PhD) into breast cancer research To recruit, support and develop young basic scientists (PhD) into mechanism-based applied research in breast cancer To recruit outstanding basic scientists into breast cancer research and provide clinical and translational expertise to this research To provide translational research mentorship, training and opportunities for investigators to develop the knowledge, skills and expertise to successfully pursue independent, extramurally-funded scholarly careers focused in translational research in breast cancer To make a high priority the recruitment of women and underrepresented minority investigators into research in breast cancer
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neoadjuvant Neratinib in Stage I-III HER2-mutated Lobular Breast Cancer
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    9759820
  • 项目类别:
  • 资助金额:
    $35.74万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    10214565
  • 项目类别:
  • 资助金额:
    $36.83万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    10458531
  • 项目类别:
  • 资助金额:
    $36.09万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
海外基金